β-Elemene Reverses Gefitinib Resistance in NSCLC Cells by Inhibiting lncRNA H19-Mediated Autophagy

β-Elemene Reverses Gefitinib Resistance in NSCLC Cells by Inhibiting lncRNA H19-Mediated Autophagy

Lung cancer is a leading cause of mortality worldwide, especially among Asian patients with non-small cell lung cancer (NSCLC) who have epidermal growth factor receptor (EGFR) mutations. Initially, first-generation EGFR tyrosine kinase inhibitors (TKIs) are commonly administered as the primary treat...

Full description

Bibliographic Details
Main Authors: Ruonan Zhang, Yintao Zheng, Qianru Zhu, Xiaoqing Gu, Bo Xiang, Xidong Gu, Tian Xie, Xinbing Sui
Format: Article
Language:English
Published: MDPI AG 2024-05-01
Series:Pharmaceuticals
Subjects:
β-elemene
gefitinib
autophagy
lncRNA H19
non-small cell lung cancer
Online Access:https://www.mdpi.com/1424-8247/17/5/626

Internet

https://www.mdpi.com/1424-8247/17/5/626

Similar Items